← All companies
Pathos AI
Series C · $62M · Oct 2024 · 3 open roles
Clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence
Backed by
- New Enterprise Associateslead
Get new roles in your inbox
Startups that just raised and are hiring. Plus an AI job concierge that emails you when a role fits what you’re after. Free.